§ 13F · FUND PROFILE
ANDERA PARTNERS.
AUM · $206M (13F)Positions · 8Turnover · n/a · Q2Filed · Jul 22, 2026
CONCENTRATION
n/a
Top 10 holdings
NEW BUYS
0
+$31M deployed
EXITS
0
No exits
SECTOR SHIFT
n/a
No prior quarter data
§ 01 · TOP HOLDINGS
The book · Q2 2026
FILED JUL 22, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q2 |
|---|---|---|---|---|---|---|
| 1 | KMTS | KESTRA MED TECHNOLOGIES LTD | 2.73M | $69M | 33.6% | +1% |
| 2 | MLYS | MINERALYS THERAPEUTICS INC | 1.59M | $43M | 20.8% | ±0% |
| 3 | AVLN | AVALYN PHARMACEUTICALS INC | 930K | $31M | 14.8% | NEW |
| 4 | AGMB | AGOMAB THERAPEUTICS NV | 1.54M | $20M | 9.7% | ±0% |
| 5 | EVMN | EVOMMUNE INC | 1.39M | $18M | 9.0% | −27% |
| 6 | IVA | INVENTIVA SA | 3.63M | $14M | 6.7% | +100% |
| 7 | ABVX | ABIVAX SA | 78K | $10M | 5.0% | ±0% |
| 8 | NYXH | NYXOAH S A | 522K | $882K | 0.4% | ±0% |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE ANDERA SIGNAL
AC read
ANDERA PARTNERS is a Other fund managing $206 million in assets. The fund runs a focused portfolio of just 8 positions.
Read the full dossier →